Lymphangioleiomyomatosis is a diffuse pulmonary infiltrate of short spindle cells, usually in association with cystic changes, occurring in women of reproductive age. LAM may also arise within lymph nodes, mediastinum, retroperitoneum and pelvis. Recent studies have demonstrated that LAM is a neoplasm arising from constitutive activation of the mammalian target of rapamycin signalling pathway dysregulated by a functional loss of tuberous sclerosis complex genes. It has also been suggested that the pulmonary lesions represent metastases from primary uterine lesions4.
Epidemiology
This is rare condition. It most often occurs sporadically, but some cases are associated with tuberous sclerosis complex (TSC). 25-40% of women with TSC develop LAM. Renal angiomyolipomas occur in most women with TSC and in about half of the cases of sporadic LAM.
Clinical features
Patients show a slow progression to respiratory failure.
Histopathology
Lungs show widespread nodules composed of myoid cells, associated with dilated lymphatics and cystic change. The myoid cells have variably clear cytoplasm.
Immunohistochemistry
5/61 |
|
positive |
|
1/61 |
|
0/61 |
|
Lymphangioleiomyomatosis may recur after lung transplantation: the recurrent LAM lesions are composed of recipient cells2.
Prognosis
Without transplantation, the median survival is 8 to 10 years3.
References
3 Hornick JL,Fletcher CD. PEComa: what do we know so far? Histopathology 2006; 48:75-82
This page last revised 6.3.2012.
©SMUHT/PW Bishop